Home
September 2008 October 2008 November 2008
Su Mo Tu We Th Fr Sa
Week 40 1 2 3 4
Week 41 5 6 7 8 9 10 11
Week 42 12 13 14 15 16 17 18
Week 43 19 20 21 22 23 24 25
Week 44 26 27 28 29 30 31

Defective Tamm-Horsfall Protein in Patients With Interstitial Cystitis - Abstract Show Comments PDF Print E-mail
  
Thursday, 15 November 2007

Division of Urology, University of California-San Diego Medical Center, San Diego

Glycotechnology Core Resource, University of California-San Diego (AD), La Jolla, California, and Georgia Urology (JGP), Cartersville, Georgia

Normal urinary Tamm-Horsfall protein shows a urothelial cytoprotective effect against potentially toxic compounds in urine that may injure the urothelium and cause bladder disease. One such disease is interstitial cystitis. In patients with interstitial cystitis this protective effect is decreased. We hypothesized that a difference in Tamm-Horsfall protein in patients with interstitial cystitis exists that may be involved in disease pathogenesis.

Using enzyme-linked immunosorbent assay the urinary Tamm-Horsfall protein concentration was determined in patients with interstitial cystitis and control subjects. Sialic acid content was measured by high performance liquid chromatography based assay. The structure of the protein glycosylation chains was analyzed using matrix assisted laser desorption/ionization-time of flight mass spectrometry

The mean Tamm-Horsfall protein concentration was not significantly different in patients with interstitial cystitis and controls (28.8 vs 28.2 mg/l urine and 36.8 vs 36.7 mug/mg creatinine, respectively, p = 0.6). The total mean sialic acid content of Tamm-Horsfall protein was almost 2-fold lower in 22 patients with interstitial cystitis compared with that in 20 controls (46.3 +/- 4.3 vs 75.3 +/- 4.1 nmol sialic acid per mg Tamm-Horsfall protein, respectively, p <0.0001). On matrix assisted laser desorption/ionization-time of flight mass spectrometry N-glycans released from Tamm-Horsfall protein revealed lower molecular weight di-antennary N-glycan structures and a resulting decrease in the number of terminal sialic acid residues in 10 patients with interstitial cystitis relative to those in 10 controls.

Tamm-Horsfall protein is qualitatively different in patients with interstitial cystitis compared to controls. These data suggest that altered Tamm-Horsfall protein may be involved in interstitial cystitis pathogenesis and it may be useful for clinical diagnosis

Written by
Parsons CL, Stein P, Zupkas P, Chenoweth M, Argade SP, Proctor JG, Datta A, Trotter RN.

Reference
J Urol. 2007 Oct 16; [Epub ahead of print]
doi:10.1016/j.juro.2007.07.125

PubMed Abstract
PMID:17945284

UroToday.com Painful Bladder Syndrome Section

Reader Comments

Please log-in or register in order to submit comments.

Powered by AkoComment!

 
User Rating: / 4
PoorBest


 
Visitor Ratings:
Healthcare Professionals:
3 (2 votes)

Patients:
4 (1 votes)

No Affiliation:
5 (1 votes)